Cargando…

Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials

Background The net clinical benefit of antithrombotic therapy (ATT) reflects the concomitant effects of bleeding and ischemic events. Objectives We sought to assess the overall effect of the modulation or escalation of ATT on all-cause mortality as well as ischemic and bleeding events. Methods We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Qiao-Yu, Wang, Zhi-Jian, Ma, Xiao-Teng, Wang, Yu-Fei, Li, Qiu-Xuan, Yang, Zhi Qiang, Lin, Xu-Ze, Pan, Liu, Gao, Fei, Yang, Li Xia, Liang, Jing, Zhou, Yu-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831688/ https://www.ncbi.nlm.nih.gov/pubmed/36343638 http://dx.doi.org/10.1055/s-0042-1757405

Ejemplares similares

Prognostic significance of multiple triglycerides-derived metabolic indices in patients with acute coronary syndrome
por: SHAO, Qiao-Yu, et al.
Publicado: (2022)

Elevated Remnant Cholesterol is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome
por: Shao, QiaoYu, et al.
Publicado: (2022)

Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography
por: Gao, Fei, et al.
Publicado: (2021)

Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
por: Shao, Qiao Yu, et al.
Publicado: (2021)

Nutritional Risk Index Improves the GRACE Score Prediction of Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Ma, Xiao-Teng, et al.
Publicado: (2021)

Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
por: Gao, Fei, et al.
Publicado: (2022)

Antithrombotic treatment strategy for patients with coronary artery ectasia and acute myocardial infarction: A case report
por: Liu, Rui-Feng, et al.
Publicado: (2022)

The triglyceride paradox in the mortality of coronary artery disease
por: Xia, Tian-li, et al.
Publicado: (2019)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020)

Impact of prior cerebrovascular events on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or percutaneous coronary intervention
por: Pan, Yu, et al.
Publicado: (2021)

Editorial: The individualization of antiplatelet therapy in coronary artery disease: escalation or de-escalations
por: Lee, Sang Yeub, et al.
Publicado: (2023)

Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta‐analysis of 16 Clinical Trials and 9185 Patients
por: Gao, Xiao‐Fei, et al.
Publicado: (2015)

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Moustafa, Abdelmoniem, et al.
Publicado: (2019)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
por: Bellettini, Elisa, et al.
Publicado: (2021)

Exosomes in Coronary Artery Disease
por: Gao, Xiao-Fei, et al.
Publicado: (2019)

The serum anion gap is associated with disease severity and all-cause mortality in coronary artery disease
por: Yang, Shi-Wei, et al.
Publicado: (2017)

Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
por: Soini, Erkki, et al.
Publicado: (2020)

Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention
por: Liu, Hangkuan, et al.
Publicado: (2021)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients
por: Ding, Ding, et al.
Publicado: (2014)

Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease
por: Yuan, Shiqi, et al.
Publicado: (2022)

High serum levels of N-epsilon-carboxymethyllysine are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery
por: Li, Le-Ying, et al.
Publicado: (2022)

The Effects of Obesity on Mortality Following Coronary Artery Bypass Graft Surgery: A Retrospective Study from a Single Center in China
por: Lv, Mengwei, et al.
Publicado: (2021)

Antithrombotic therapy in peripheral arterial disease
por: Espinola-Klein, Christine, et al.
Publicado: (2022)

Diagnosis of coronary artery spasm by ergonovine provocation test of radial artery
por: Li, Ye-fei, et al.
Publicado: (2021)

Therapeutic Exosomes in Prognosis and Developments of Coronary Artery Disease
por: Chen, Ai-Qun, et al.
Publicado: (2021)

New Antithrombotic Drugs in Acute Coronary Syndrome
por: Zwart, Bastiaan, et al.
Publicado: (2020)

Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis
por: Li, Jing-Xiu, et al.
Publicado: (2018)

Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China
por: Han, Xiao-Ning, et al.
Publicado: (2020)

Short-term antithrombotic strategies after left atrial appendage occlusion: a systematic review and network meta-analysis
por: Wang, Li-Man, et al.
Publicado: (2023)

Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
por: Mo, Zhao-Jun, et al.
Publicado: (2023)

Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography
por: Chu, Zhi-gang, et al.
Publicado: (2010)

Escalation of Antithrombotic Therapy Should Be Considered in the Presence of Intraluminal Prosthetic Graft Thrombus Following Endovascular Aneurysm Repair
por: Russell, Terri-Ann, et al.
Publicado: (2022)

Aim Before You Shoot: Within Graft Thrombus After EVAR is Generally Benign and Escalation of Antithrombotic Therapy is Not
por: Bastos Gonçalves, Frederico, et al.
Publicado: (2022)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Study on syndrome differentiation and treatment in the management of chronic stable coronary artery disease to improve quality of life
por: Bi, Ying-Fei, et al.
Publicado: (2018)

Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions
por: Caracciolo, Alessandro, et al.
Publicado: (2019)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qb68rifdun5r9ren0v12u1hoeb